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Abstract
Huntington’s disease (HD) is centrally characterized by motor, neurocognitive
and psychiatric symptoms, but impaired emotional decoding abilities have also
been reported. However, more complex affective abilities are still to be explored,
and particularly empathy, which is essential for social relations and is impaired in
various psychiatric conditions. This study evaluates empathic abilities and social
skills in pre-clinical and clinical HD, and explores the distinction between two
empathy sub-components (emotional-cognitive). Thirty-six HD patients (17 pre-
clinical) and 36 matched controls filled in the Empathy Quotient Scale, while
controlling for psychopathological comorbidities. At the clinical stage of HD, no
global empathy impairment was observed but rather a specific deficit for the
cognitive sub-component, while emotional empathy was preserved. A deficit
was also observed for social skills. Pre-clinical HD was not associated with any
empathy deficit. Emotional deficits in ...
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a b s t r a c t
Huntington’s disease (HD) is centrally characterized by motor, neurocognitive and psychiatric symptoms,
but impaired emotional decoding abilities have also been reported. However, more complex affective
abilities are still to be explored, and particularly empathy, which is essential for social relations and is
impaired in various psychiatric conditions. This study evaluates empathic abilities and social skills in pre-
clinical and clinical HD, and explores the distinction between two empathy sub-components (emotional-
cognitive). Thirty-six HD patients (17 pre-clinical) and 36 matched controls ﬁlled in the Empathy Quo-
tient Scale, while controlling for psychopathological comorbidities. At the clinical stage of HD, no global
empathy impairment was observed but rather a speciﬁc deﬁcit for the cognitive sub-component, while
emotional empathy was preserved. A deﬁcit was also observed for social skills. Pre-clinical HD was not
associated with any empathy deﬁcit. Emotional deﬁcits in clinical HD are thus not limited to basic
emotion decoding but extend towards complex interpersonal abilities. The dissociation between im-
paired cognitive and preserved emotional empathy in clinical HD reinforces the proposal that empathy
subtypes are sustained by distinct processes. Finally, these results underline the extent of distinct af-
fective and social impairments in HD and the need to grasp them in clinical contexts.
& 2016 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Huntington’s disease (HD) is a genetically inherited neurode-
generative disease classically associated with a triad of motor,
neurocognitive and psychiatric symptoms (Roos, 2010). Beyond
these well-established impairments, other deﬁcits have been
documented, particularly the presence of emotional disturbances
as HD is characterized by impaired ability to identify the six
classically described (Darwin 1872; Ekman, 1993; Ekman and
Friesen, 1971) basic facial emotional expressions: several studies
have initially evidenced a speciﬁc deﬁcit for the identiﬁcation of
disgust (Sprengelmeyer, 2007), but more recent works have shown
that this deﬁcit is generalized to other negative emotions like
anger, fear or sadness (Johnson et al., 2007). Critically, this deﬁcit is
present at the clinical stage of the disease (i.e. among symptomatic
patients presenting motor impairments) but might already exist at
the pre-clinical stage [i.e. among non-symptomatic persons car-
rying HD’s gene (Johnson et al., 2007)]. Moreover, as this impair-
ment appears speciﬁc to emotional processing (Sprengelmeyer,
2007) and is also present for emotional prosody (Snowden et al.,
2008) as well as for facial expression of emotions (Trinkler et al.,
2013), HD appears associated with a generalized impairment in
the detection and expression of emotions (Henley et al., 2012).
Efﬁcient emotional processing is a crucial skill to maintain
adapted interpersonal relations, and these emotional deﬁcits thus
negatively impact social life in HD as they are correlated with
reduced functional capacity in everyday life (Craufurd and Snow-
den 2002). It is now clearly established that emotional
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impairments have deleterious consequences on personal and
professional life in HD (Ille et al., 2011a). Moreover, at a clinical
level, it has been shown in several psychiatric and medical con-
ditions that the quality of social support and interpersonal en-
vironment has a crucial impact on treatment compliance (Dour
et al., 2014), underlining the role of affective and social factors on
treatment response. In view of these arguments, it appears crucial
to further explore the extent of these emotional deﬁcits and their
links with interpersonal impairments in HD. Indeed, despite the
exploration of basic emotional decoding and the proposal that
higher-level affective abilities could also be impaired, these more
complex emotional abilities involved in social interactions have
been little explored in HD, hampering to obtain an exhaustive
view of the emotional impairments.
Among the emotional competences that should be more thor-
oughly investigated, empathy occupies a core position as it is an
essential ability to build and maintain affective bonds between
mother and child, partners, and then larger social groups (Singer,
2006). Empathy is globally deﬁned as the aptitude to understand
and respond to other’s feelings, thoughts, or emotions by ima-
gining oneself in another individual’s position (Decety and Jack-
son, 2006). Empathy is not a unitary concept but rather a multi-
faceted construct involving at least two distinct components
(Lawrence et al., 2004), namely: (1) an emotional component
linked to the ability of experiencing others’ emotional states, and
(2) a cognitive component related to perspective-taking ability
allowing to understand others’ mental states (e.g., thoughts,
goals). The validity of this emotional-cognitive distinction has
been experimentally explored by the observation of speciﬁc deﬁ-
cits in psychiatric states: autism (Smith, 2009) and euthymic bi-
polar disorder (Shamay-Tsoory et al., 2009) are associated with
marked cognitive empathy deﬁcit but preserved emotional em-
pathy. Conversely, alcohol-dependence leads to impaired emo-
tional empathy with preserved cognitive empathy (Maurage et al.,
2011). These results clearly call for completing the classical ex-
ploration of global empathy by a separate exploration of its two
sub-components.
Empathic abilities have also been recently explored in a wide-
range of neuropsychiatric conditions, notably showing a general
empathy deﬁcit in Parkinson’s disease (Narme et al., 2013), and a
dissociation between preserved emotional and impaired cognitive
empathy in Alzheimer’s disease (Nash et al., 2007). These results
underline the critical role played by empathy deﬁcits in neuro-
degenerative states and lead to crucial theoretical and clinical
implications (Kemp et al., 2012). Surprisingly however, there is
currently a striking scarcity of knowledge on empathy abilities in
HD. Indeed, on the one hand, some studies have explored cogni-
tive processes that are related to empathy, showing deﬁcits for
social cognition (Snowden et al., 2008), perspective taking (Brüne
et al., 2011) or intention attribution (Baez et al., 2015) in clinical
HD. Nevertheless, the use of cognitive-demanding tasks do not
allow to exclude that these deﬁcits are partly related to more
general cognitive impairments (e.g., working memory), and these
studies did not directly measure empathy. On the other hand, only
one study has explored empathy in HD (Trinkler et al., 2013), de-
scribing preserved empathic abilities in clinical HD. Although
constituting a valuable ﬁrst exploration, these preliminary results
presented three main shortcomings: First, the evaluation of em-
pathy relied on highly criticized questionnaires (Baron-Cohen and
Wheelwright, 2004) unable to dissociate emotional and cognitive
sub-components. Second, while clinical psychiatric diagnoses
constituted exclusion criteria, sub-clinical anxiety and depression
were not controlled for and might have inﬂuenced empathy scores
(Grynberg et al., 2010). Third, the experimental sample was ex-
clusively constituted of clinical HD patients presenting motor and
cognitive impairments, preventing any conclusion concerning the
presence of empathy deﬁcits in pre-clinical HD and their evolution
across the successive stages of HD.
To overcome these limitations, the present study explored
empathy in pre-clinical and clinical HD, with a strict control of
psychopathological variables and by means of a validated ques-
tionnaire [Empathy Quotient questionnaire, EQ (Baron-Cohen and
Wheelwright, 2004)] allowing the separate exploration of emo-
tional and cognitive empathy. As earlier results have suggested
signiﬁcant perspective taking and social cognition impairments in
clinical HD (Baez et al., 2015; Brüne et al., 2011; Snowden et al.,
2008), we hypothesized that this group would show massive
deﬁcits for cognitive empathy. Conversely, as interpersonal and
emotional functions have been repeatedly described as preserved
in pre-clinical HD (Kipps et al., 2007; Sprengelmeyer et al., 1996), it
can be hypothesized that this group will present unaltered em-
pathic abilities. Finally, a “social skills” subscale was included in
the EQ, allowing to explore the global ability to behave appro-
priately in interpersonal situations (Lawrence et al., 2004). A last
hypothesis was thus that clinical HD participants would, in view of
their reduced capacity to maintain efﬁcient social interactions, be




Thirty-six adults (16 women) with a genetically conﬁrmed HD
diagnosis (Huntington’s Disease Participants, HDP) were recruited in
the HD care units of four Belgian hospitals. Participants were ﬁrst
contacted by their general practitioner or neurologist who explained
the aims of the study, and were then referred to the principal in-
vestigator. All participants had a family history of HD and completed
a genetic blood test assessing the HD’s cytosine-adenine-guanine
(CAG) expansion. HD is characterized by elongated CAG repeat on at
least one allele of the chromosome 4 on the Huntingtin gene. All
participants presented an expansion of at least 36 CAG repeats (Roos,
2010). Among them, 17 were at pre-clinical phase (carrying the HD’s
gene but non-symptomatic, HDP-) while 19 were at clinical phase
(symptomatic participants with motor impairments, HDPþ). The
disease stage was assessed by their neurologist, their nurse, and a
psychologist with expertise in HD, according to Roos’ criteria (Roos,
2010): among HDP , 14 were at the A2 stage (i.e. gene carrier, pre-
manifest stage) and three were at the A3 stage (i.e. transition phase,
ongoing changes at behavioural and motor levels); among HDPþ , 12
were at the B1 stage (i.e. clinical stage I, with initial neurological,
cognitive and psychiatric symptoms, chorea being the most promi-
nent symptom) and seven were at the B2 stage (i.e. clinical stage II,
with generalized motor disturbance and increased cognitive-psy-
chiatric symptoms). The mean illness duration among HDPþ was
6.87 years (SD¼5.41). The mean number of CAG repeats of the longer
allele was 42.82 (SD¼3.81) in HDP and 42.84 (SD¼3.30) in HDPþ .
Moreover, HD participants’ global functioning was assessed by a
neurologist through the Clinical Global Impression Scale (CGI), a
widely-used clinical tool evaluating the psychological, social and
occupational abilities on a scale ranging from 1 (normal) to 7 (among
the most ill patients). In HDP , CGI scores were between 1 (normal)
and 2 (borderline) (M¼1.24, SD¼0.44). In HDPþ , CGI scores were
between 3 (mildly ill) and 5 (markedly ill) (M¼4.26, SD¼0.65).
HD participants were matched for age, gender, and education
with 36 control participants (CP). Two subgroups of CP were de-
termined (CP , CPþ) respectively matched with HDP and
HDPþ . Groups’ characteristics appear in Table 1. Exclusion criteria
for both groups included major medical problems, neurological
disease (except HD for the HD groups), psychiatric disorder and
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substance abuse, assessed through the Mini International Neu-
ropsychiatric Interview. While CP participants were free of any
medication, four HDP and 12 HDPþ participants were under
stabilized psychotropic medication, namely benzodiazepines (lor-
azepam, alprazolam or zolpidem, one HDP , eight HDPþ), anti-
depressants (escitalopram or paroxetine, one HDP , 10 HDPþ)
and/or antipsychotic (olanzapine or aripiprazole, two HDP , one
HDPþ) drugs. Moreover, four HDPþ participants were treated
with medication to limit choreatic symptoms (Tetrabenazine).
Education level was assessed according to the number of years of
education completed since starting primary school. Participants
were provided with full details regarding the aims of the study and
gave their written informed consent. The study was approved by
the Ethical Committee of the Medical School (Université cath-
olique de Louvain) and carried out according to the Declaration of
Helsinki. Participants were paid 25 euros for their participation.
This experiment was part of a larger project investigating cognitive
and emotional impairments in HD.
2.2. Procedure and measures
2.2.1. Control measures
Validated self-completion questionnaires were used to assess
depression [Beck Depression Inventory (Beck and Steer, 1987)] and
trait anxiety [Spielberger Trait Anxiety Inventory (Spielberger
et al., 1983)] in both groups.
2.2.2. Empathy measure
The evaluation of empathy was based on the EQ (Baron-Cohen
and Wheelwright, 2004), a self-administered questionnaire com-
prising 60 items (40 empathy related, 20 ﬁllers), each scored on a
4-point Likert scale (from “totally agree” to “totally disagree”). Each
empathy item was scored (0–2), leading to a total empathy score
(0–80). Three subscales were also computed, each comprising
5 items [0–10 (Lawrence et al., 2004; Muncer and Ling, 2006)]: (i)
“Cognitive empathy” (e.g., “I can tune into how someone else feels
rapidly and intuitively”), (ii) “Emotional reactivity-empathy” (e.g., “I
tend to get emotionally involved with a friend’s problems”) and (iii)
“Social skills” (e.g., “I do not tend to ﬁnd social situations confusing”).
The EQ shows good test-retest reliability (Lawrence et al., 2004),
and internal consistency for both global and subscales scores
(Muncer and Ling, 2006).
2.3. Data analytic plan
Statistical analyses were performed using the SPSS software
package. Group and subgroup comparisons were based on Student
t-tests. P-values were adjusted for multiple comparisons using
Benjamini & Hochberg’s correction.
3. Results
3.1. Control measures
3.1.1. General group comparison
As described in Table 1, HDP and CP did not signiﬁcantly differ
in terms of age [t(70)¼ .35, p¼ .73], gender [χ2(1,n¼72)¼ .23,
p¼ .63], education [t(70)¼ .46, p¼ .65], depression [t(70)¼ .47,
p¼ .64] and anxiety [t(70)¼1.13, p¼ .26].
3.1.2. Subgroups comparisons
A similar absence of signiﬁcant group differences was obtained
for the comparison between: (1) HDP and CP , for age
[t(32)¼ .09, p¼ .93], gender [χ2(1,n¼34)¼ .13, p¼ .71], education
[t(32)¼1.25, p¼ .22], depression [t(32)¼ .02, p¼ .98] and anxiety
[t(32)¼ .02, p¼ .99], and (2) HDPþ and CPþ , for age [t(36)¼ .42,
p¼ .68], gender [χ2(1,n¼38)¼ .11, p¼ .75], education [t(36)¼ .77,
p¼ .45], depression [t(36)¼ .66, p¼ .51] and anxiety [t(36)¼1.55,
p¼ .13].
3.2. Empathy measure
3.2.1. General group comparison
As shown in Fig. 1 (part A), HDP and CP did not signiﬁcantly
differ for the total empathy quotient [t(70)¼1.69, p¼ .10], emo-
tional reactivity [t(70)¼ .21, p¼ .83] and social skills [t(70)¼1.02,
p¼ .31]. However, HDP presented lower scores than CP for cogni-
tive empathy [t(70)¼2.16, p¼ .03, d¼ .51].
3.2.2. Subgroups comparisons
As shown in Fig. 1 (part B), (1) HDP- and CP- did not sig-
niﬁcantly differ on any experimental data: total empathy quotient
[t(32)¼ .88, p¼ .38], cognitive empathy [t(32)¼1.00, p¼ .32],
emotional reactivity [t(32)¼ .15, p¼ .88] and social skills [t(32)¼
1.04, p¼ .31]; (2) HDPþ and CPþ did not signiﬁcantly differ for
total empathy quotient [t(36)¼1.56, p¼ .13] and emotional re-
activity [t(36)¼ .15, p¼ .89], but HDPþ presented lower scores
than CPþ for cognitive empathy [t(36)¼2.03, p¼ .04, d¼ .67] and
social skills [t(36)¼2.78, p¼ .01, d¼ .91], indexing reduced cogni-
tive empathy and social skills in clinical HD.
3.3. Complementary analyses
Complementary analyses were performed to test:
– The biasing effect of medication: Pearson’s correlations were
conducted in HDP and HDPþ groups between psychotropic
medication (i.e. benzodiazepines and antidepressant) and ex-
perimental results (i.e. total score and subscales). No signiﬁcant
correlation was observed (p4 .05 for every correlation);
– The biasing effect of psychopathological variables: Pearson’s
Table 1
Demographic and psychopathological measures for clinical (HDPþ) and pre-clinical (HDP) Huntington’s disease patients, and matched controls (CPþ and CP): Mean(SD)
HDP CP
HDPþ (N¼19) HDP (N¼17) HDP (N¼36) CPþ (N¼19) CP (N¼17) CP (N¼36)
Demographic measures
Age 51.58 (12.3) 38.94 (13.3) 45.61 (14.1) 49.63 (16.3) 38.53 (13.1) 44.39 (15.7)
Gender ratio (F/M) 10/9 6/11 16/20 9/10 5/12 14/22
Educational level (in years) 11.63 (3.4) 13.06 (2.7) 12.31 (3.1) 12.37 (2.5) 11.47 (4.5) 11.94 (3.5)
Psychopathological measures
Beck Depression Inventory 14.53 (9.9) 11.53 (8.8) 13.11 (9.4) 12.74 (6.4) 11.59 (7.6) 12.19 (6.9)
Trait Anxiety Inventory 44.74 (12.1) 44.53 (11.3) 44.64 (11.5) 39.42 (8.9) 44.59 (8.8) 41.86 (9.1)
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correlations were conducted in the whole sample and in each
group between psychopathological variables (i.e. depression and
anxiety) and empathy measures (i.e. total score and subscales).
No signiﬁcant correlation was observed (p4 .05 for every
correlation).
– The links between empathy subscales: Pearson’s correlations were
conducted in the whole sample between empathy subscales (i.e.
cognitive empathy, emotional reactivity, social skills). Signiﬁcant
correlations were found between cognitive empathy and emo-
tional reactivity (r¼ .274, p¼ .02), cognitive empathy and social
skills (r¼ .271, p¼ .02), as well as between emotional reactivity
and social skills (r¼ .25, p¼ .03).
4. Discussion
This study was the ﬁrst to investigate (1) empathy abilities in
HD with a strict control of potentially biasing comorbidities,
(2) the possible differential impairment between emotional and
cognitive empathy in HD, (3) the speciﬁc empathy deﬁcits related
to the pre-clinical and clinical stages of the disease, and (4) the
relations between empathy abilities and social functioning in HD.
It should ﬁrst be noted that no global deﬁcit was observed in HD
when empathy was considered as a unitary construct. This result is
in line with earlier ones (Trinkler et al., 2013), and thus reinforces,
with a more validated empathy scale and a better group matching
on psychopathological variables, the proposal that HD does not
lead to a reduction of global empathy scores. However, as men-
tioned above, this unitary approach of empathy is now outdated
and the absence of deﬁcit for general empathy might thus mask
actual deﬁcits for speciﬁc sub-components, this hypothesis being
investigated here by exploring group differences on EQ subscales.
This disjointed exploration of emotional and cognitive empathy
led to the major result of this study, namely the dissociation be-
tween impaired cognitive and preserved emotional empathy sub-
components in clinical HD. This impairment is speciﬁcally present
in clinical HD, pre-clinical HD patients showing preserved em-
pathy on both subscales. Noteworthy, as psychopathological co-
morbidities were controlled for and as no correlation was found
between empathy measures and depression-anxiety scores, this
deﬁcit cannot be attributed to the presence of comorbid depres-
sive or anxious symptomatology. As cognitive empathy is part of
social cognition abilities, the observed impairment reinforces
earlier studies showing alterations in this ability among clinical
HD by means of various experimental tasks [social story sequen-
cing (Brüne et al., 2011), faux-pas detection, complex mental states
decoding (Baez et al., 2015)]. However, as these earlier results
were based on complex tasks, the deﬁcits observed might have
been partly due to more general cognitive impairments and not to
social cognition deﬁcits per se. The present results, showing a
deﬁcit for cognitive empathy in HD by means of a measure re-
quiring limited cognitive resources, are unlikely to result from
cognitive demands. Conversely, the absence of deﬁcits for emo-
tional empathy might appear surprising in view of the widely
described impairment for emotional abilities (Johnson et al., 2007)
and of the extent of emotional alterations in this pathology
(Henley et al., 2012). However, this result is coherent with the
proposal (Trinkler et al., 2013) that clinical HD might be associated
with a generalized dysfunction of the brain structures underlying
identiﬁcation and expression of emotions but with a preservation
of the cerebral network related to semantic emotional processing
and emotional concepts’ understanding, as examined by the EQ
emotional subscale.
Interestingly, similar empathy pattern had already been re-
ported in psychiatric disorders [autism (Smith, 2009), bipolar
disorder (Shamay-Tsoory et al., 2009)], but also in neurological
states like Alzheimer’s disease (Nash et al., 2007). The description
of a dissociation between preserved emotional and altered cog-
nitive empathy in HD thus suggests that different psychopatho-
logical and neurodegenerative states might be associated with
similar dissociation in empathy deﬁcits. Such dissociation further
reinforces recent models postulating that cognitive and affective
empathy, while sharing a common basis (as illustrated by the
correlations observed in the present study), are different abilities
underlaid by distinct cerebral networks (Singer, 2006). Moreover,
as cognitive empathy appears to strongly rely on ventromedial-
orbitofrontal cortices (Shamay-Tsoory et al., 2003), and as ven-
tromedial-orbitofrontal impairments have been described in HD
Fig. 1. Global group results (Part A) and subgroups results (Part B) for EQ total score and subscales. NS, Non-signiﬁcant; *po .05; **po .01. Error bars represent standard
errors of the mean.
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(Ille et al., 2011b), these brain structures might play a crucial role
in the cognitive empathy impairment observed in neurodegen-
erative diseases.
Beyond the dissociation between emotional and cognitive
empathy, results also showed that clinical HD is associated with a
reduction on the social skills subscale. This factor is considered as
reﬂecting the ability to intuitively understand the social rules and
norms involved in social situations and to behave appropriately in
interpersonal relationships (Muncer and Ling, 2006). While this
social skills subscale has been shown to be separated from other
empathy sub-components, it appears to partly rely on cognitive
empathy (Lawrence et al., 2004). The observation of a joint deﬁcit
for these two subscales in clinical HD is thus coherent and indexes
a global impairment in the identiﬁcation and response to others’
mental states in social situations.
A last central result is the difference observed between pre-
clinical and clinical HD groups. HD is a progressive neurological
disorder and these populations thus strongly vary in terms of age,
clinical HD groups being systematically older than pre-clinical
ones. As empathy is inﬂuenced by age (Bailey et al., 2008), a direct
group comparison on empathy would have been strongly biased
by age difference. To avoid this age bias, the present study has thus
been based on the comparison between each HD group and a
control group matched for gender, age and education. Results
clearly showed that pre-clinical HD is not related to any empathy
deﬁcit and that cognitive empathy-social skills impairments only
appear at the clinical stage of HD. Pre-clinical HD’s results are not
in line with earlier ones showing impaired emotion decoding in a
large sample (Johnson et al., 2007). This discrepancy might index
that empathy abilities and emotional recognition rely on distinct
cognitive processes and cerebral correlates, as it has been sug-
gested by the similar dissociation observed in other populations
(Nash et al., 2007). More globally, this clear distinction between
pre-clinical and clinical HD leads to the proposal that empathy
impairment is not a mere consequence of carrying HD’s gene but
rather appears at the clinical stage of the disease. Further studies
are needed to determine the precise cerebral correlates of this
deﬁcit, but it might be related to the progressive neurodegenera-
tion of brain structures involved in cognitive empathy (particularly
orbitofrontal-ventromedial areas).
Although our results appear sound in view of the large effect
sizes observed, the present data should be replicated and extended
on larger samples as the current study was based on small groups
in comparison with several earlier ones focusing on emotional
processes (e.g., Johnson et al., 2007). Centrally, the self-report
nature of the questionnaire might have inﬂuenced the results, as
clinical HD patients might present reduced insight or self-eva-
luation abilities (Callaghan et al., 2010). While self-report ques-
tionnaires are the most widely used and validated way to measure
empathy abilities, these abilities should be further investigated by
directly comparing self-reported measures with more direct em-
pathy and social skills measures in HD. Finally, clinical HD patients
are characterized by globally reduced cognitive abilities and, while
the experimental approach used in the present study did not re-
quire complex cognitive processing, these reduced abilities may
have inﬂuenced the results. Future studies exploring empathy in
HD should thus take cognitive functioning into account.
Despite these limitations, the present results have crucial im-
plications at experimental and clinical levels. They centrally show
that, beyond the global preservation of empathy indexed by the EQ
total score and explored earlier (Trinkler et al., 2013), clinical HD is
characterized, independently of comorbid depressive and anxious
symptoms, by a dissociation between impaired cognitive em-
pathy-social skills and preserved emotional empathy. Moreover,
no deﬁcit is present in sub-clinical HD, suggesting that empathy
impairments are progressively appearing during HD’s evolution
and developing jointly with motor-cognitive deﬁcits. At the ther-
apeutic level, these results claim for taking emotional and inter-
personal deﬁcits into account in clinical HD and for applying re-
habilitation programs focused on empathy abilities in this popu-
lation, as such programs have been validated in other clinical
contexts and as improving interpersonal abilities might increase
treatment compliance (Riess and Kraft-Todd, 2014). In view of the
wide-range psychological and cognitive deﬁcits presented by
clinical HD patients, these empathy rehabilitation tools should
nevertheless be adapted to ﬁt with patients’ abilities. Moreover,
another treatment avenue would be to inform and educate pa-
tients’ relatives and caretakers about the actual consequences of
empathy deﬁcit on everyday life and interpersonal relations, in
order to help them adapting and improving their social interac-
tions with patients.
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